Clinical Trial Update: Antithrombotic Triple Therapy in Humans [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating antithrombotic triple therapy in patients with atrial fibrillation and acute coronary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Syndrome

Snippet

Sponsor: Medical University of Vienna | Conditions: Atrial Fibrillation, Acute Coronary Syndrome | Phase 4 | Status: COMPLETED